Raymond James Financial’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Raymond James Financial's IRD Position: Q3 2026 in Review
Raymond James Financial increased its Opus Genetics (IRD) stake by 13% in Q3 2026, buying an estimated $8.26K and bringing the position to 16,997 shares worth $82.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5246.
Raymond James Financial first reported a position in IRD in Q4 2024 and has held it in 8 quarters since. The position peaked at $88.8K in Q1 2026. 112 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Raymond James Financial held 16,997 shares of Opus Genetics worth $82.3K as of Q3 2026.
- Raymond James Financial bought 1,989 Opus Genetics shares in Q3 2026, an estimated $8.26K.
- Opus Genetics made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #5246 holding.
- Raymond James Financial first reported a position in Opus Genetics in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Opus Genetics position peaked at $88.8K in Q1 2026.
- 112 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.